A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Maverick Capital LTD holds 10,047,520 shares of WVE stock, worth $143 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares
10,047,520
Previous 7,669,361 31.01%
Holding current value
$143 Million
Previous $38.3 Million 115.28%
% of portfolio
1.71%
Previous 0.75%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.12 - $9.01 $12.2 Million - $21.4 Million
2,378,159 Added 31.01%
10,047,520 $82.4 Million
Q2 2024

Aug 14, 2024

SELL
$4.38 - $6.48 $81,984 - $121,292
-18,718 Reduced 0.24%
7,669,361 $38.3 Million
Q1 2024

May 15, 2024

SELL
$3.54 - $6.84 $2.69 Million - $5.2 Million
-759,725 Reduced 8.99%
7,688,079 $47.4 Million
Q4 2023

Feb 14, 2024

BUY
$4.16 - $6.87 $7.71 Million - $12.7 Million
1,853,485 Added 28.11%
8,447,804 $42.7 Million
Q3 2023

Nov 14, 2023

SELL
$3.56 - $5.75 $8,754 - $14,139
-2,459 Reduced 0.04%
6,594,319 $37.9 Million
Q1 2023

May 15, 2023

SELL
$3.58 - $6.3 $1.79 Million - $3.16 Million
-500,886 Reduced 7.06%
6,596,778 $28.6 Million
Q4 2022

Feb 14, 2023

SELL
$3.18 - $7.0 $2.25 Million - $4.95 Million
-707,555 Reduced 9.07%
7,097,664 $49.7 Million
Q2 2022

Aug 15, 2022

BUY
$1.23 - $3.25 $2.72 Million - $7.19 Million
2,211,830 Added 39.54%
7,805,219 $25.4 Million
Q4 2021

Feb 14, 2022

BUY
$3.14 - $5.15 $7.54 Million - $12.4 Million
2,400,000 Added 75.16%
5,593,389 $17.6 Million
Q3 2021

Nov 15, 2021

BUY
$4.89 - $7.12 $514,711 - $749,436
105,258 Added 3.41%
3,193,389 $15.6 Million
Q2 2021

Aug 16, 2021

BUY
$5.65 - $7.47 $27,854 - $36,827
4,930 Added 0.16%
3,088,131 $20.6 Million
Q1 2021

May 17, 2021

BUY
$5.61 - $12.01 $17.3 Million - $37 Million
3,083,201 New
3,083,201 $17.3 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.